Stock Research for BLFS

BLFS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BLFS Stock Chart & Research Data

The BLFS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BLFS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BLFS Due diligence Resources & Stock Charts

The BLFS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BLFS Detailed Price Forecast - CNN Money CNN View BLFS Detailed Summary - Google Finance
Yahoo View BLFS Detailed Summary - Yahoo! Finance Zacks View BLFS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View BLFS Trends & Analysis - Trade-Ideas Barrons View BLFS Major Holders - Barrons
NASDAQ View BLFS Call Transcripts - NASDAQ Seeking View BLFS Breaking News & Analysis - Seeking Alpha
Spotlight View BLFS Annual Report - CompanySpotlight.com OTC Report View BLFS OTC Short Report - OTCShortReport.com
TradeKing View BLFS Fundamentals - TradeKing Charts View BLFS SEC Filings - Bar Chart
WSJ View Historical Prices for BLFS - The WSJ Morningstar View Performance/Total Return for BLFS - Morningstar
MarketWatch View the Analyst Estimates for BLFS - MarketWatch CNBC View the Earnings History for BLFS - CNBC
StockMarketWatch View the BLFS Earnings - StockMarketWatch MacroAxis View BLFS Buy or Sell Recommendations - MacroAxis
Bullish View the BLFS Bullish Patterns - American Bulls Short Pains View BLFS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View BLFS Stock Mentions - StockTwits PennyStocks View BLFS Stock Mentions - PennyStockTweets
Twitter View BLFS Stock Mentions - Twitter Invest Hub View BLFS Investment Forum News - Investor Hub
Yahoo View BLFS Stock Mentions - Yahoo! Message Board Seeking Alpha View BLFS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for BLFS - SECform4.com Insider Cow View Insider Transactions for BLFS - Insider Cow
CNBC View BLFS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BLFS - OTC Markets
Yahoo View Insider Transactions for BLFS - Yahoo! Finance NASDAQ View Institutional Holdings for BLFS - NASDAQ


Stock Charts

FinViz View BLFS Stock Insight & Charts - FinViz.com StockCharts View BLFS Investment Charts - StockCharts.com
BarChart View BLFS Stock Overview & Charts - BarChart Trading View View BLFS User Generated Charts - Trading View




Latest Financial News for BLFS


BioLife Solutions: On a Strong Footing
Posted on Thursday September 13, 2018

BioLife Solutions (BLFS) develops, manufactures, and commercializes cell and tissue hypothermic storage and cryopreservation freeze media. BioLife Solutions generated revenues of $5.18 million in the second quarter compared to $2.56 million in the second quarter of 2017. For fiscal 2018 and fiscal 2019, BioLife is expected to generate revenues of $19.89 million and $28.36 million, respectively, compared to $11.02 million in fiscal 2017.


Analysts Still Bullish about BioLife Solutions
Posted on Thursday September 13, 2018

BioLife Solutions (BLFS) generated a net income of $1.05 million in the second quarter compared to a net loss of $768,212 in the second quarter of 2017. That translates to net income per share of $0.05 in the second quarter. Its net loss per share was $0.06 in the second quarter of 2017.


Audentes Therapeutics’ Promising Product Pipeline
Posted on Thursday September 13, 2018

Gene therapy involves repairing or replacing disease-causing genes. Investor interest in gene therapy stocks has remained buoyant throughout 2018. According to Allied Market Research, the gene therapy market is expected to grow at a 33.3% CAGR (compound annual growth rate) to $4.4 billion by 2023.


Local bioscience firm nets $5 million investment
Posted on Wednesday September 05, 2018

Albuquerque's SAVSU Technologies has landed a major investment from a Washington-based company.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.